2025-07-22 – Press Releases – www.prnewswire.com
MELBOURNE, Australia and INDIANAPOLIS, July 22, 2025 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today provides an update on its commercial and operational performance for the quarter ended 30 June 2025 (Q2 2025). All figures are in USD unless stated…
